|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Leyvraz, Serge; Konietschke, Frank; Peuker, Caroline; Schuette, Moritz; Kessler, Thomas; Ochsenreither, Sebastian; Ditzhaus, Marc; Spruenken, Erin D.; Doerpholz, Gina; Lamping, Mario; Rieke, Damian T.; Klinghammer, Konrad; Burock, Susen; Ulrich, Claas; Poch, Gabriela; Schaefer, Reinhold; Klauschen, Frederick; Joussen, Antonia; Yaspo, Marie-Laure und Keilholz, Ulrich
(2022):
Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study.
In: European Journal of Cancer, Bd. 169: S. 146-155
2018
Rieke, Damian T.; Lamping, Mario; Schuh, Marissa; Le Tourneau, Christophe; Baste, Neus; Burkard, Mark E.; Metzeler, Klaus H.; Leyvraz, Serge und Keilholz, Ulrich
(2018):
Comparison of Treatment Recommendations by Molecular Tumor Boards Worldwide.
In: Jco Precision Oncology, Bd. 2
2017
Casali, Paolo G.; Zalcberg, John; Cesne, Axel le; Reichardt, Peter; Blay, Jean-Yves; Lindner, Lars H.; Judson, Ian R.; Schoffski, Patrick; Leyvraz, Serge; Italiano, Antoine; Grunwald, Viktor; Pousa, Antonio Lopez; Kotasek, Dusan; Sleijfer, Stefan; Kerst, Jan M.; Rutkowski, Piotr; Fumagalli, Elena; Hogendoorn, Pancras; Litiere, Saskia; Marreaud, Sandrine; Graaf, Winette van der; Gronchi, Alessandro und Verweij, Jaap
(2017):
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
In: Journal of Clinical Oncology, Bd. 35, Nr. 15: S. 1713-1720